🔎 Trials Near Me

Dachaigh › Astrocytoma

Sgrùdaidhean clionaigeach Astrocytoma a’ fastadh anns na SA

Tha 45 sgrùdaidhean airson Astrocytoma a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.

Bailtean leis na sgrùdaidhean as motha

Le stàit

Sgrùdaidhean air an ùrachadh o chionn ghoirid

Teacsa sgrùdaidh oifigeil (Beurla)

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

A’ fastadhÌre 1/2
Aoisean 18 gu 130 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05417594

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

A’ fastadhÌre 3
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07215910

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT03896568

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06047379

VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma

A’ fastadhÌre 2
Aoisean 18 gu 98 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT07831369

A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

A’ fastadhÌre 1
Aoisean 19 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT05698524

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

A’ fastadhÌre 1/2
Aoisean 2 gu 24 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT04923126

FearLess in NeuroOncology

A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06989086

Targeted Pediatric High-Grade Glioma Therapy

A’ fastadhSgrùdadh amharc
12 Months – 39 Years · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT05839379

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

A’ fastadhÌre 1
36 Months – 22 Years · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT03911388

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT06860594

Serial MRI Scans During Radiation Therapy

A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT04188535

Study of Olutasidenib and Temozolomide in HGG

A’ fastadhÌre 2
Aoisean 12 gu 39 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT05303519

Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

A’ fastadhÌre 1
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 14 Lùna 2026 · NCT06344130

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT07733674

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Iuch 2026 · NCT04623931

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

A’ fastadhÌre 1 tràthFàilte do shaor-thoilich fhallain
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT06333899

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Ògmh 2026 · NCT07468136

A Study of 177Lu-PSMA-617 in People With Gliomas

A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT07223034

Loupe-Based Intraoperative Fluorescence Imaging

A’ fastadhSgrùdadh amharc
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 3 Ògmh 2026 · NCT04780009

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.